Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.88 |
| ▸ | CRBN | Q96SW2 | 5/20 | 0.74 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.31 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.31 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Pyrrolidone SCHEMBL3356160 | 1.00 | — | — | |
| 2-Pyrrolidone SCHEMBL28107340 | 0.95 | OR51E2 (0.79) | OR51E2CRBNFKBP5KDM4EGAA | |
| 2-Pyrrolidone SCHEMBL14977810 | 0.95 | OR51E2 (0.79) | OR51E2CRBNFKBP5KDM4EGAA | |
| 2-Pyrrolidone SCHEMBL14977562 | 0.95 | OR51E2 (0.79) | OR51E2CRBNFKBP5KDM4EGAA | |
| 2-Pyrrolidone SCHEMBL6929736 | 0.95 | OR51E2 (0.79) | OR51E2CRBNFKBP5KDM4EGAA | |
| 2-Pyrrolidone SCHEMBL353224 | 0.95 | OR51E2 (0.79) | OR51E2CRBNFKBP5KDM4EGAA | |
| 2-Pyrrolidone SCHEMBL27827832 | 0.94 | — | — | |
| 2-Pyrrolidone SCHEMBL4299593 | 0.94 | — | — | |
| 2-Pyrrolidone SCHEMBL9304498 | 0.94 | OR51E2 (1.00) | OR51E2CRBNFKBP5KDM4EGAA | |
| 2-Pyrrolidone SCHEMBL2389 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4294357-A1 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND ALUMINA | The Procter & Gamble Company (US) | 2023-12-27 | — | — | EP | claimed |
| EP-4294354-A1 | HYDRATING ORAL CARE COMPOSITIONS COMPRISING PEROXIDE | The Procter & Gamble Company (US) | 2023-12-27 | — | — | EP | claimed |
| EP-4294355-A1 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND COMPATIBLE ABRASIVE | The Procter & Gamble Company (US) | 2023-12-27 | — | — | EP | claimed |
| EP-4294356-A1 | ORAL CARE COMPOSITION COMPRISING PEROXIDE | The Procter & Gamble Company (US) | 2023-12-27 | — | — | EP | claimed |
| US-20220265531-A1 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND COMPATIBLE ABRASIVE | THE PROCTER & GAMBLE COMPANY | 2022-08-25 | — | — | US | claimed |
| WO-2022178531-A1 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND ALUMINA | THE PROCTER & GAMBLE COMPANY (US) | 2022-08-25 | — | — | WO | claimed |
| US-20220265532-A1 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND ALUMINA | THE PROCTER & GAMBLE COMPANY | 2022-08-25 | — | — | US | claimed |
| CN-107252398-A | Oral care Lightening compositions | 高露洁-棕榄公司 | 2017-10-17 | — | — | CN | claimed |
| CN-1089251-C | Steam sterilization using anhydrous hydrogen peroxide source | JOHNSON & JOHNSON MEDICAL (US) | 2002-08-21 | — | — | CN | claimed |
| CN-1112446-A | Steam sterilization using anhydrous hydrogen peroxide source | JOHNSON & JOHNSON MEDICAL (US) | 1995-11-29 | — | — | CN | claimed |
| EP-3894388-A1 | (METH)ACRYLATE-FUNCTIONALIZED WAXES AND CURABLE COMPOSITIONS MADE THEREWITH | Henkel IP & Holding GmbH (DE) | 2021-10-20 | — | — | EP | disclosed |
| EP-3119698-B1 | HYDROGEN PEROXIDE VAPOUR GENERATING PRODUCT AND METHOD | COOLSAN HYGIENE SOLUTIONS PTY LTD (AU) | 2020-09-09 | — | — | EP | disclosed |
| WO-2020119908-A1 | (METH)ACRYLATE-FUNCTIONALIZED WAXES AND CURABLE COMPOSITIONS MADE THEREWITH | Henkel IP & Holding GmbH (DE) | 2020-06-18 | — | — | WO | disclosed |
| WO-2018215789-A1 | ORAL CARE COMPOSITION, PROCESS FOR PREPARATION AND METHOD OF USE THEREOF | BIOFILM LIMITED (GB) | 2018-11-29 | — | — | WO | disclosed |
| US-9770402-B2 | Oral care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2017-09-26 | — | — | US | disclosed |
| US-20060171905-A1 | Dental bleaching compositions having a protective coating applied thereto | ULTRADENT PRODUCTS, INC. | 2006-08-03 | — | — | US | disclosed |
| WO-2006034249-A2 | ANTIMICROBIAL AMORPHOUS COMPOSITIONS | ACRYMED, INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| CN-1089251-C | Steam sterilization using anhydrous hydrogen peroxide source | JOHNSON & JOHNSON MEDICAL (US) | 2002-08-21 | — | — | CN | disclosed |
| CN-1121314-A | Improvements in or relating to contrast agents | NYCOMED IMAGING AS (NO) | 1996-04-24 | — | — | CN | disclosed |
| CN-1112446-A | Steam sterilization using anhydrous hydrogen peroxide source | JOHNSON & JOHNSON MEDICAL (US) | 1995-11-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220265532-A1 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND ALUMINA | CAT, POLN, SOD3 | OR51E2 1684/4885CRBN 1022/4885FKBP5 4770/4885 |
| US-20220265531-A1 | ORAL CARE COMPOSITIONS COMPRISING PEROXIDE AND COMPATIBLE ABRASIVE | LBR, AP3S1, PHOSPHO1 | OR51E2 3551/4885CRBN 1341/4885FKBP5 4157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.